China’s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids
China’s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price...
China’s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price...
The Shanghai Medical Products Administration (SMPA) has revoked the winning bid of India-based Sun Pharmaceutical...
In a departure from previous practice, the 7th national volume-based procurement (VBP) round will not...
China’s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related...